64. Which of the following situations requires a DUR by a pharmacist?
Answer: D
A therapeutic duplication is identified
A therapeutic duplication occurs when a patient is prescribed two or more medications that have similar therapeutic effects, which can increase the risk of adverse effects or overdose. In such cases, a drug utilization review (DUR) by a pharmacist is essential to ensure patient safety and appropriate medication management.
A) A patient requests a brand name medication
This situation does not inherently require a DUR, as a patient may request a brand name medication for various reasons, such as familiarity or preference. The pharmacist can address this request without needing to review the patient's entire medication profile for potential duplications.
B) A physician prescribes a brand name medication
While a physician's prescription of a brand name medication might prompt a review of the overall treatment plan, it does not specifically require a DUR unless there are concerns about potential therapeutic duplications or interactions. The mere act of prescribing a brand name medication does not indicate a need for deeper scrutiny.
C) A medication is a look-alike/sound-alike drug
The identification of a look-alike/sound-alike drug may raise concerns about medication errors, but it does not necessitate a DUR unless it is associated with a therapeutic duplication or a significant interaction with the patient's current medications. The pharmacist's role here would be to ensure proper dispensing rather than conducting a comprehensive review.
D) A therapeutic duplication is identified
This situation directly necessitates a DUR by a pharmacist. When a therapeutic duplication is identified, it indicates that the patient may be receiving more than one medication that serves the same therapeutic purpose, which can lead to increased risks of adverse effects. The pharmacist must evaluate the medications involved to determine the safest course of action for the patient.
Conclusion
The identification of a therapeutic duplication is a critical situation that requires a DUR to safeguard the patient's health by preventing potential medication-related issues. Other options do not present the same level of risk that would warrant a comprehensive review, making option D the only correct choice in this context. A DUR is essential for maintaining effective and safe medication therapy in the presence of therapeutic duplications.